These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

389 related articles for article (PubMed ID: 26161477)

  • 21. What Does Provider Status Mean for Pharmacists?
    Consult Pharm; 2015 Aug; 30(8):478-80. PubMed ID: 26260644
    [No Abstract]   [Full Text] [Related]  

  • 22. Toward permissionless innovation in health care.
    Adams AJ
    J Am Pharm Assoc (2003); 2015; 55(4):359-62. PubMed ID: 26161479
    [No Abstract]   [Full Text] [Related]  

  • 23. Sweeping CMS Proposal Would Acknowledge Role of Pharmacists.
    Consult Pharm; 2015 Sep; 30(9):544. PubMed ID: 26350895
    [No Abstract]   [Full Text] [Related]  

  • 24. Prescribing opportunities for pharmacists in rural areas.
    Ahmad A; Khan MU
    Res Social Adm Pharm; 2016; 12(5):811-2. PubMed ID: 27157865
    [No Abstract]   [Full Text] [Related]  

  • 25. APhA House of Delegates: guiding the future direction of the Association and profession.
    Bzowyckyj A; M Zavod R; Hobbs A
    J Am Pharm Assoc (2003); 2013; 53(4):346-52. PubMed ID: 23892802
    [No Abstract]   [Full Text] [Related]  

  • 26. Supply chain management of health commodities for reducing global disease burden.
    Chukwu OA; Ezeanochikwa VN; Eya BE
    Res Social Adm Pharm; 2017; 13(4):871-874. PubMed ID: 27720436
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Emerging Developments in Pharmacists' Scope of Practice to Address Unmet Health Care Needs.
    Burns AL
    Ann Pharmacother; 2016 Sep; 50(9):785-7. PubMed ID: 27340143
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Health care reform and the role of the pharmacist.
    Simenson S; Nau DP; Reed B
    J Am Pharm Assoc (2003); 2009; 49(3):356, 360-2. PubMed ID: 19443316
    [No Abstract]   [Full Text] [Related]  

  • 29. COVID-19 related regulatory change for pharmacists - The case for its retention post the pandemic.
    Lynch M; O'Leary AC
    Res Social Adm Pharm; 2021 Jan; 17(1):1913-1919. PubMed ID: 32893134
    [TBL] [Abstract][Full Text] [Related]  

  • 30. APhA2017 House of Delegates: Opportunities for collaboration: The impact of science and research on pharmacy practice.
    Urick B
    J Am Pharm Assoc (2003); 2017; 57(4):429-430. PubMed ID: 28712459
    [No Abstract]   [Full Text] [Related]  

  • 31. Pharmacist 'provider status' legislation introduced into the Senate.
    Young D
    Am J Health Syst Pharm; 2003 Aug; 60(15):1502. PubMed ID: 12951746
    [No Abstract]   [Full Text] [Related]  

  • 32. How to implement a "standard of care" regulatory model for pharmacists.
    Adams AJ; Chopski NL; Adams JA
    J Am Pharm Assoc (2003); 2024; 64(3):102034. PubMed ID: 38354978
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mapping the route to medication therapy management documentation and billing standardization and interoperabilility within the health care system: meeting proceedings.
    Millonig MK
    J Am Pharm Assoc (2003); 2009; 49(3):372-82. PubMed ID: 19357067
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The outlook for pharmacist initiation and modification of drug therapy.
    Shefcheck SL; Thomas J
    J Am Pharm Assoc (Wash); 1996 Oct; NS36(10):597-604. PubMed ID: 8908936
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Report of the 2010 APhA House of Delegates: actions of the legislative body of the American Pharmacists Association.
    J Am Pharm Assoc (2003); 2010; 50(4):471-2. PubMed ID: 20621862
    [No Abstract]   [Full Text] [Related]  

  • 36. Pharmacy-related position papers from the APHA Pharmacy Services Committee.
    Bush PJ
    Drug Intell Clin Pharm; 1982 Sep; 16(9):673-9. PubMed ID: 7128459
    [No Abstract]   [Full Text] [Related]  

  • 37. New York pharmacists push for CDTM.
    Traynor K
    Am J Health Syst Pharm; 2013 Nov; 70(21):1870, 1872. PubMed ID: 24128953
    [No Abstract]   [Full Text] [Related]  

  • 38. The Continuum of Pharmacist Prescriptive Authority.
    Adams AJ; Weaver KK
    Ann Pharmacother; 2016 Sep; 50(9):778-84. PubMed ID: 27307413
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Grassroots lobbying: an important tool for pharmacy. Lobbying can lead to acknowledgment as health care providers.
    Lipowski E
    J Am Pharm Assoc (2003); 2004; 44(1):6-7. PubMed ID: 15008167
    [No Abstract]   [Full Text] [Related]  

  • 40. Residency requirement for pharmacists providing direct patient care.
    Nahata MC
    Ann Pharmacother; 2010 Nov; 44(11):1822-5. PubMed ID: 20923948
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.